Professor and Discipline Lead, Microbiology and Immunology, Western University of Health Sciences, United States
Dr. Vishwanath Venketaraman is a highly accomplished professor and Discipline Lead for Microbiology and Immunology at Western University of Health Sciences. He holds a Ph.D. in Immunology from the National Institute for Research on Tuberculosis (1996) and has conducted extensive research in tuberculosis, HIV, and type 2 diabetes. Dr. Venketaraman has published 144 papers and edited several books on topics like host immune responses and tuberculosis. His research has been supported by NIH, AHA, and various foundations. He’s widely recognized for his teaching and mentoring of students. 🧑🔬📚🏆
Profile
Google Scholar
Scopus
Education and Experience
Dr. Vishwanath Venketaraman earned his Ph.D. in Immunology from the National Institute for Research on Tuberculosis (1996). He began his career with postdoctoral work in Italy, Michigan, and New Jersey. In 2003, he joined the College of Osteopathic Medicine at Western University of Health Sciences, where he progressed from Assistant to Full Professor. He has mentored over 400 students in research and has received numerous accolades for his teaching, including the Best Professor Award (2016-2019). His professional journey reflects his deep commitment to both education and scientific advancement. 🎓👨🔬📖
Professional Development
Dr. Vishwanath Venketaraman has a strong commitment to professional growth, both as an educator and a researcher. He has received the Provost’s Distinguished Scholar Award and numerous faculty excellence awards. As an NIH reviewer, he contributes significantly to research funding decisions. He has organized workshops, chaired scientific sessions, and been invited as a speaker at prestigious events. Dr. Venketaraman is also a prolific editor and reviewer for top journals. His leadership in research committees and mentoring over 400 students further exemplifies his dedication to both personal and professional development. 🌱🏆📚
Research Focus
Dr. Vishwanath Venketaraman’s research focuses on understanding host immune responses to Mycobacterium tuberculosis, particularly in the context of HIV and type 2 diabetes. His laboratory conducts preclinical studies and clinical trials to explore host-directed therapies for tuberculosis. His work emphasizes the development of adjunctive treatments for tuberculosis, aimed at enhancing the body’s natural immune defense. In addition, he investigates the role of glutathione in immune responses and its therapeutic potential in diseases like HIV and tuberculosis. His research has been funded by prestigious organizations such as the NIH and the American Heart Association. 🔬🦠💉
Publications
- “Cytolytic P2X purinoceptors” (1998) – 347 citations 📖
- “Analysis of the delta variant B.1.617.2 COVID-19” (2021) – 326 citations 🦠
- “Glutathione as a marker for human disease” (2018) – 235 citations 🧬
- “General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens” (2020) – 220 citations 🦠
- “Glutathione and infection” (2013) – 210 citations 🧪
- “Mechanisms of nausea and vomiting: current knowledge” (2021) – 181 citations 🤢
- “Type 2 Diabetes Mellitus and Altered Immune System” (2019) – 156 citations 🩺
- “Mechanisms of Control of Mycobacterium tuberculosis by NK Cells” (2015) – 148 citations 🦠
- “Investigating the causes for decreased levels of glutathione in individuals with type II diabetes” (2015) – 135 citations 🧪
- “Glutathione and Nitrosoglutathione in Macrophage Defense” (2005) – 133 citations 🧬